MD Anderson Cancer Center shared a post on X:
“For patients with relapsed or refractory large B cell lymphoma and secondary central nervous system involvement, Lisocabtagene Maraleucel (liso-cel) is a feasible and effective option, our Dr. Sairah Ahmed reported at ASH24 this morning.”
More posts featuring MD Anderson Cancer Center.